Newsroom

News

A dedicated building is being constructed in Hannover for the Centre for Individualised Infection Medicine (CiiM), a joint initiative of the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH). The groundbreaking ceremony for the new building with 2100 square metres of effective space was held today in the presence of numerous guests from politics and science. CiiM, which was initially founded in 2015 as a virtual centre, is addressing urgent challenges in infectious medicine with the aim of individual prognosis and diagnosis of infectious diseases and derived optimised and customised prevention and personalised therapy for the benefit of the individual patient. The construction costs are covered by the federal government, the state of Lower Saxony, the Helmholtz Association and the HZI.

23.11.2022

CiiM

News

The Faculty of Medicine has awarded Professor Dirk Heinz an honorary doctorate – for his outstanding achievements in the fields of structural biology and infection research as well as for his shaping the German research landscape for the better.

08.11.2022

HZI Campus

News

With the help of the eHealth system SORMAS (short for “Surveillance Outbreak Response Management and Analysis System”), epidemics can be detected and contained at an early stage. For its contribution to global health, the system developed under the leadership of the Helmholtz Centre for Infection Research (HZI) in Braunschweig has now been rewarded with a place among the three finalists for the Zayed Sustainability Award 2023. The winner of the $600,000 prize will be selected in January 2023 from the three selected projects, which competed against more than 900 other projects in the health category.

07.11.2022

HZI Campus

News

Scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Institute for Molecular Infection Biology (IMIB) in Würzburg want to better understand how the oral cavity germ Fusobacterium nucleatum is exactly linked to various cancer diseases. To unravel the molecular strategies of these bacteria, the team has developed new genetic tools. They discovered an adaptation factor that may help the microorganisms colonize tumor cells. The findings contribute to the search for new therapeutic targets and were published recently in the journal PNAS (The Proceedings of the National Academy of Sciences).

03.11.2022

HIRI

News

The Federal Agency for Disruptive Innovation (SPRIND) is pleased to announce the participants of the second phase of the SPRIND Challenge "A Quantum Shift for New Antiviral Agents". Six teams will each receive up to 1.5 million for the next twelve months to further develop new drug candidates against viral diseases. The team “PROTAC-powered antivirals” led by Prof Mark Brönstrup, head of the department “Chemical Biology” at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, receives funding for the development of a platform for broadly effective antiviral agents. In addition, the team “Mucboost” with participation of Dr Christian Sieben, head of the junior research group “Nano Infection Biology” at the HZI, will continue to receive funding. The “CRISPR Antivirals” team includes two HZI researchers, Prof Chase Beisel, head of the department “RNA Synthetic Biology” at the Helmholtz Institute for RNA-based Infection Research (HIRI), and Prof Claus-Michael Lehr, head of the department “Drug Delivery across Biological Barriers” at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). HIRI and HIPS are HZI sites in cooperation with Julius Maximilians University (JMU) Würzburg and Saarland University, respectively.

26.10.2022

HZI Campus

HIPS

HIRI

Interview

Martin Korte researches the influence of infections and infection-associated inflammations on neurodegenerative diseases that damage, for example, learning processes or memory. Korte is group leader of the “Neuroinflammation and Neurodegeneration” research group at the Helmholtz Centre for Infection Research (HZI) and director of the Zoological Institute at the Technische Universität Braunschweig where he also holds a professorship for Cellular Neurobiology. A newly emerging field of research are the symptoms summarily known as "long COVID", which continue to manifest for months in about ten per cent of patients after overcoming a COVID-19 disease. In this interview, Martin Korte explains these long-term consequences, which are the subject of his new book (in German).

15.10.2022

HZI Campus

Back to the first page
...
44
45
46
47
...
154

HZI in the media

... fünf Teams durch, darunter PROTON vom Helmholtz-Zentrum für Infektionsforschung. Dieses entwickelt einen neuartigen Wirkstoff gegen ...

22.03.2026

Ad Hoc News

Vor allem durch die Coronapandemie sind Forschende des Helmholtz-Zentrums für Infektionsforschung in den vergangenen Jahren bundesweit bekannt geworden. Auf welche Themen die Einrichtung für die Zukunft setzt.

20.03.2026

Deutsches Ärzteblatt

... beschäftigt sich daneben unter dem Dach des Helmholtz Institutes für Pharmazeutische Forschung Saarland (HIPS) ...

18.03.2026

Biermann Medizin

... Ausbau von Produktions- und Vermarktungskapazitäten.

Das Helmholtz-Zentrum für Infektionsforschung HZI begrüßt den Erhalt der GMP- ...

18.03.2026

Bionity.COM

... der Universität zu Lübeck, des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig, der Medizinischen Hochschule Hannover ...

17.03.2026

Biermann Medizin

Vorsorge Das Coronavirus hält die Welt nicht mehr in Atem. Doch was, wenn ein anderer gefährlicher Erreger auftaucht? So wappnet sich unser Gesundheitssystem

16.03.2026

Apotheken Umschau

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

14.03.2026

ARD Mediathek

... der Medizinischen Hochschule Hannover und dem Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig neue Wirkstoffe ...

13.03.2026

MTA Dialog

... späten 1990ern hob sie der am Saarbrücker Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) tätige ...

08.03.2026

Saarbrücker Zeitung

European institutions, including Germany’s Helmholtz Institute for RNA-based Infection Research, Helmholtz Center for Infection Research,

06.03.2026

Clinical Lab Products

Die Zellen kontrollieren die Reaktion des Immunsystems und verhindern Schäden durch Selbstangriffe. Forschende arbeiten daran, sie zur Therapie einzusetzen.

05.03.2026

NDR Norddeutscher Rundfunk

Nachwuchsgruppe „Nanoinfektionsbiologie“ am HZI. Diese Lücke soll das Projekt ONEMUC (Respiratorischer Mukus als One Health-Schnittstelle) ...

03.03.2026

DeutschesGesundheitsPortal

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.